《公司業績》日清食品(01475.HK)首三季純利2.37億元 按年升2.54%
日清食品(01475.HK)公布,截至2022年9月30日止九個月,純利為2.37億元,按年增2.54%,每股盈利為22.73元。期內收入為30.81億元,按年增7.81%。
集團表示,即使在實施價格調整後,主要產品如出前一丁品牌在中國內地及香港的銷售量仍有所增加。由於價格調整及銷量增加的影響抵銷了原材料價格的大幅上漲,故此溢利亦按年上升。另外,當地貨幣兌日圓換算升值亦對收入及溢利產生更正面的影響。
本期毛利率為31.6%,較2021年的31.5%輕微增長0.1個百分點,主要由於期內在香港及中國內地實施價格調整,抵銷了原材料價格大幅上漲所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.